Codex DNA Inc - ESG Rating & Company Profile powered by AI
Check the end of the webpage for potential risks for Codex DNA Inc based on sector, location and marketcap. This SDG score for Codex DNA Inc represents the company's reporting of the UN SDGs. Alternative companies in the scoring industry group for Codex DNA Inc are displayedin the table.
Codex DNA Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.8; made up of an environmental score of 6.4, social score of 0.0 and governance score of 8.0.
4.8
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
764 | Zoetis Inc | 4.9 | High |
764 | iCo Therapeutics Inc | 4.9 | High |
816 | Codex DNA Inc | 4.8 | High |
816 | Chemomab Therapeutics Ltd | 4.8 | High |
816 | Althea Group Holdings Ltd | 4.8 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Codex DNA Inc have an accelerator or VC vehicle to help deliver innovation?
Does Codex DNA Inc disclose current and historical energy intensity?
Does Codex DNA Inc report the average age of the workforce?
Does Codex DNA Inc reference operational or capital allocation in relation to climate change?
Does Codex DNA Inc disclose its ethnicity pay gap?
Does Codex DNA Inc disclose cybersecurity risks?
Does Codex DNA Inc offer flexible work?
Does Codex DNA Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Codex DNA Inc disclose the number of employees in R&D functions?
Does Codex DNA Inc conduct supply chain audits?
Does Codex DNA Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Codex DNA Inc conduct 360 degree staff reviews?
Does Codex DNA Inc disclose the individual responsible for D&I?
Does Codex DNA Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Codex DNA Inc disclose current and / or historical scope 2 emissions?
Does Codex DNA Inc disclose water use targets?
Does Codex DNA Inc have careers partnerships with academic institutions?
Did Codex DNA Inc have a product recall in the last two years?
Does Codex DNA Inc disclose incidents of discrimination?
Does Codex DNA Inc allow for Work Councils/Collective Agreements to be formed?
Has Codex DNA Inc issued a profit warning in the past 24 months?
Does Codex DNA Inc disclose parental leave metrics?
Does Codex DNA Inc disclose climate scenario or pathway analysis?
Does Codex DNA Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Codex DNA Inc disclose the pay ratio of women to men?
Does Codex DNA Inc support suppliers with sustainability related research and development?
Does Codex DNA Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Codex DNA Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Codex DNA Inc involved in embryonic stem cell research?
Does Codex DNA Inc disclose GHG and Air Emissions intensity?
Does Codex DNA Inc disclose its waste policy?
Does Codex DNA Inc report according to TCFD requirements?
Does Codex DNA Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Codex DNA Inc disclose energy use targets?
Does Codex DNA Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Codex DNA Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Codex DNA Inc
These potential risks are based on the size, segment and geographies of the company.
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.